Culture protein companies faces lot of hurdles while walking on the road to success; however, the most significant setback is that it is rather hard to find a growth media that is not only accessible but also affordable. On top of it all, it is also necessary that it doesn’t depend on animals. A trend has been noted in this market wherein the companies are trying their best to keep themselves separated from fetal bovine seru, (GBS) controversy. However, other options are turning out to be few and far between while also being tremendously expensive.
Recently, an interesting development has been noted in the Cell Culture Media Market with Turtle Tree Scientific (B2B arm of cellular ag company Turtle Tree Labs) joining hands with JSBiosciences. They have decided to merge their research and resources for the development of cell culture media. This move by the companies might turn out to be huge for all the players in the market as the objective of the collaboration is to try and bring down the cost of production of cell-cultured products so that it could be manufactured at industrial scale.
Turtle Tree Labs, is a Singapore based company that is popular for its technology that has the ability to produce human milk from mammalian cells. Its Turtle Tree Scientific Arm was launched recently with the objective of creating food-grade growth factors for cultured protein products. Its collaborating partner JSBiosciences is expected to be a valuable partner for this research as it has a tremendous track record when it comes to development of mammalian cell structure at industrial level. It has been revealed that JSBiosciences will contribute media formulation services and food-grade basal media to Turtle Tree. This would empower the companies to get a “upstream” production costs reduced enough to enable commercial scale manufacturing of cell-cultured products.
This partnership entered into by Turtle Tree Scientific is second major partnership in the year 2021itself. A while ago, the company had also announced that it would be collaborating with Dyadic International, a biotech company. They would be putting combined effort for development of recombinant food-grade growth factors for such proteins that can be grown in high produce but with lower costs inside bioreactors.
These research partnerships may turn out to be quite advantageous for Cell Culture Media Market as it would lead to development of approaches and technologies that would lead to larger production methods that are also cost efficient. Since this has been one of the biggest problems surrounding the market, the future holds promise for the producers as they soon might be able to increase their level of business with new technologies